| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 26/01/2024 | 22:07 | Alliance News |  Sanofi and Regeneron celebrate Dupixent's FDA approval | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 11/12/2023 | 20:25 | Alliance News | Leading pharmaceutical firms highlight positive trial data on lymphoma | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 16/09/2022 | 06:46 | Alliance News | Regeneron, Sanofi drug effective for young children with severe eczema | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 09/09/2022 | 07:40 | Alliance News | Regeneron shares surge on positive Eylea trial data | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 02/06/2022 | 16:18 | Alliance News | Sanofi grants Regeneron global license for cancer treatment Libtayo | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 31/05/2022 | 07:54 | Alliance News | US FDA accepts Regeneron and Sanofi's Dupixent for priority review | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 28/03/2022 | 07:18 | Alliance News | IN BRIEF: Sanofi, Regeneron hail positive results in prurigo nodularis | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 28/02/2022 | 07:21 | Alliance News | Sanofi and Regeneron note positive new data for Dupixent | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 18/02/2022 | 11:26 | Alliance News | Regeneron and Sanofi stop trial of skin condition treatment Dupixent | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 19/01/2022 | 08:32 | Alliance News | Sanofi and Regeneron's Dupixent meets endpoints for skin treatment | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 12/11/2021 | 16:54 | Alliance News | TOP NEWS: Roche and Regeneron Covid antibody cocktail approved in EU | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 25/10/2021 | 07:50 | Alliance News | Sanofi and Regeneron's Dupixent trial meets primary endpoints | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 14/10/2021 | 14:18 | Alliance News | US FDA accepts Regeneron's REGEN-COV application for priority review | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 30/09/2021 | 07:36 | Alliance News | Regeneron, Roche drug cocktail reduces Covid-19 viral load - UK study | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 30/08/2021 | 08:23 | Alliance News | Sanofi, Regeneron's Dupixent works for children with atopic dermatitis | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 27/07/2021 | 13:56 | Alliance News | AstraZeneca partners with Regeneron to research obesity treatment | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 20/07/2021 | 07:58 | Alliance News | Roche and Regeneron's Covid antibody cocktail gets Japan approval | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 28/06/2021 | 07:16 | Alliance News | Sanofi, Regeneron report well-established safety profile of Dupixent | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 25/06/2021 | 07:48 | Alliance News | Sanofi and Regeneron's cancer treatment Libtayo gets approval in EU | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 23/03/2021 | 08:26 | Alliance News | TOP NEWS: Novartis, Regeneron Covid antibody cocktail excels in trials | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 15/03/2021 | 10:20 | Alliance News | Regeneron, Sanofi report positive phase three trial results of Libtayo | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 26/02/2021 | 18:25 | Alliance News | EU Medicines Regulator Approves Regeneron Coronavirus Therapy | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 25/02/2021 | 15:05 | Alliance News | Roche, Regeneron Note Positive Findings For REGEN-COV In Covid-19 | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 22/02/2021 | 21:13 | Alliance News | IN BRIEF: Sanofi, Regeneron Get US FDA Approval For Lung Cancer Drug | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 13/01/2021 | 07:24 | Alliance News | Roche Says US To Buy Extra Doses Of Regeneron's Covid Antibody Coctail | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 01/12/2020 | 23:27 | Alliance News | Regeneron Pharmaceuticals Developing Nasal Spray To Prevent Covid-19 | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 30/11/2020 | 10:59 | Alliance News | Sanofi And Regeneron Announce New Dupixent Approval In Children | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 26/10/2020 | 13:52 | Alliance News | Sanofi, Regeneron Say Dupixent Lowers Esophagitis Symptoms | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 16/10/2020 | 15:19 | Alliance News | Sanofi And Regeneron Get European Boost For Dupixent | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 13/10/2020 | 07:35 | Alliance News | Sanofi And Regeneron Say Dupixent Significantly Reduces Asthma Attacks | LSE:0R2M | Regeneron Pharmaceuticals Inc |